Best Continuous Glucose Monitors 2026

Dexcom Stelo keeps first at 9.3 and my ranking holds. Today's note is for a specific group of readers, the people still wearing a Dexcom G6, because the calendar has quietly run out on that sensor.

Dexcom told customers it would stop manufacturing the G6 after 1 July 2026. Pharmacies and distributors can keep selling remaining stock for a while, and Dexcom says plainly that it cannot guarantee how long. If your prescription still reads G6, the time to move is now, while you still have sensors in the drawer to bridge any insurance paperwork. Dexcom points G6 users to the G7 or the G7 15 Day.

My list already reflects that move. The G7 15 Day sits second at 9.1 because the extra five days of wear per sensor lowers daily cost for prescription users, and the standard G7 holds fourth at 8.9. If you manage diabetes with insulin, ask your clinician for the 15 Day version by name. If you are a non-insulin user buying over the counter, Stelo gives you Dexcom sensor performance on a 15 day wear cycle at the best daily cost in my table, which is why it holds first.

The same report notes that a next-generation G8 platform is in development with a smaller form factor and more built-in sensing, and it carries no public timeline. I would never delay a G6 switch for it.

One timing note for gadget buyers. Apple Watch Series 12 goes on sale this Friday alongside iPhone 18 Pro. A watch is a convenient glucose display and the sensor stays the thing doing the measuring, so spend on sensor supply first. Prime Big Deal Days on 6 and 7 October is a sensible window for accessories like overpatches and phone mounts.

Dexcom Stelo holds first at 9.3 and my ranking carries forward. This week I want to do the arithmetic that decides most purchases in this category, which is cost per day of wear.

Stelo runs a 15 day sensor sold in two packs on a subscription, and that structure is why it scores 9.5 on daily cost while carrying Dexcom sensor performance. The G7 15 Day at 9.1 in second and Abbott Lingo at 9.0 in third sit close behind on the same logic, longer sensor life spreading the same hardware across more days. Eversense 365 at 8.6 takes the idea to its limit with an implanted sensor that runs a full year, and it earns a perfect 10 on wear time.

Where the arithmetic turns against you is the coached programs. Levels at 8.5, Nutrisense at 8.4 and Signos at 8.2 all score 6.0 to 6.2 on daily cost, because you pay for software and human coaching on top of the sensors. Nutrisense earns its 9.5 coaching score with real dietitian contact, so the honest question is whether you will use the human on the other end.

Two things worth noting this month. Regulatory reviewers keep describing continuous glucose monitoring as the wearable category with the most established clinical evidence and the clearest standing, which is why I hold this list to a higher accuracy bar than step counters. And iOS 27 arrived on 14 September with a rebuilt Siri running as its own app, so expect glucose apps to start wiring readings into that assistant layer over the next few releases.

My advice stays the same. Buy a single sensor before you commit to a subscription. Two weeks of data tells you whether you will act on what you learn, and that is the only thing that makes this spending worthwhile.

Dexcom Stelo keeps first place at 9.3 and my ranking holds this week. It is an over-the-counter glucose biosensor that sits on the back of the upper arm for up to 15 days and sends readings straight to a phone app. It stays on top because it brings Dexcom sensor accuracy to adults who do not use insulin, with the longest wear time among no-prescription options.

This week I want to talk about the prescription side of the list, because a transition is under way. Dexcom said it would stop manufacturing the G6 after 1 July 2026 and move users fully to G7. If you still have G6 sensors at home, plan your switch with your clinic now. The G7 15 Day, which holds second at 9.1, is the natural upgrade: a smaller all-in-one sensor with a warm-up of about 30 minutes and wear that stretches to fifteen and a half days.

Abbott's FreeStyle Libre 3 Plus holds fifth at 8.8 and is set to pair with Insulet's Omnipod 5 automated insulin delivery system during 2026. That integration matters for pump users who prefer Libre sensors, and diaTribe's tech tracker is the resource I check for timing updates. Abbott's Libre Duo, the ketone and glucose sensor authorized in late August, is still waiting for its US launch.

Abbott Lingo stays third at 9.0 for the friendliest coaching app in the wellness tier, and Eversense 365 holds sixth at 8.6 for anyone who wants a single implanted sensor that lasts a full year.

In Taiwan, Libre sensors are the most widely available through pharmacies and clinics. If you are paying out of pocket, ask about sensor pricing per 14 days, since that decides your yearly cost far more than the reader or app.

Dexcom Stelo keeps first place at 9.3 and the ranking holds this week. Stelo is an over-the-counter glucose biosensor that sticks to the back of the upper arm for up to 15 days and streams readings to a phone app. FDA cleared it for adults who do not use insulin, and it remains my top pick because it pairs Dexcom sensor accuracy with the longest wear time among the no-prescription options.

No new clearance or launch landed in the past seven days, so the most important recent development is still Abbott's Libre Duo. FDA authorized it in late August as the first device to continuously monitor both ketones and glucose, with a US launch planned later in 2026. I will rate it once it ships and I can compare its app and price against the sensors here.

The Dexcom G7 15 Day holds second at 9.1. It is the prescription G7 sensor with an extended wear period, and it suits people managing diabetes who want fewer sensor changes each month. Abbott Lingo stays third at 9.0. Lingo is cleared as a general wellness tool for adults, and its coaching-style app is the most approachable I have used for someone curious about how meals affect their glucose.

A clear safety point. The over-the-counter sensors are designed for people who do not use insulin. Anyone taking insulin, or anyone with a history of low blood sugar episodes, should use a prescription CGM chosen with their clinician.

For wellness buyers, my advice is to wear one sensor, log meals honestly for two weeks, and look for patterns. That short experiment usually answers the question that made you curious.

The significant development in this category is that FDA authorised the first device to continuously monitor both ketone and glucose levels, Abbott's Libre Duo, with a US launch planned later in 2026. Abbott also received European approval for the Libre Duo and Libre Duo 10 Day, the former for adults eighteen and older and the latter for people aged two and up.

Continuous ketone monitoring is genuinely new. For people managing type 1 diabetes, ketone levels are the signal that precedes diabetic ketoacidosis, and detecting that trend continuously is a meaningful clinical capability. I will place the Libre Duo in this ranking when it is available and I have accuracy data.

For everything else, the ranking holds. The Dexcom Stelo holds first at 9.3 because it is available over the counter without a prescription and its accuracy is solid, which makes it the practical entry point for anyone wanting to understand their glucose response.

One framing point I want to make clearly. If you have diagnosed diabetes, your CGM choice should be made with your clinical team, because compatibility with your insulin delivery system and insurance coverage matter more than any consumer comparison. This ranking is most useful for people without diabetes who want metabolic data, and for people with diabetes as a starting point for a conversation with their doctor.

Check daily cost carefully. Sensor replacement schedules differ, and the annual cost difference between options is substantial.

The Dexcom Stelo holds first at 9.3 and the reason is access. It is available without a prescription, the app explains what a reading means in language a first-time user can act on, and the fifteen-day wear cycle keeps the running cost sensible. A CGM that a curious person can actually buy and understand does more good than a clinically superior device sitting behind a referral. The Dexcom G7 15 Day at 9.1 is the better sensor and the right choice for anyone managing diagnosed diabetes, with the accuracy and alerting that decision requires. Abbott's Lingo at 9.0 has the best-designed metabolic coaching layer and is the one I recommend for people using a CGM to understand food responses. What I want to say clearly this month: the wearable industry keeps pushing toward non-invasive glucose sensing and IFA was full of adjacent claims, and nothing on that show floor measures glucose without a sensor under the skin. Treat any wrist device claiming otherwise with suspicion. For readers in Taiwan, the practical constraint is supply. CGM availability here runs through pharmacy and clinic channels with prices well above the US list, so budget for roughly double what American reviews quote, and check whether the app you want supports a Taiwan account before you commit to a brand.

Dexcom Stelo holds first at 9.3 and the reason is access. It is available over the counter without a prescription, it costs roughly $99 for a month of sensors, and the accuracy is Dexcom-grade. For the enormous population of people who want metabolic data without a diabetes diagnosis, that combination is what makes wearing a CGM realistic instead of aspirational. The G7 15 Day at 9.1 is the clinical-grade choice and the extended wear time genuinely changes the cost calculation. Fifteen days per sensor against ten means roughly a third fewer sensors per year, and for someone paying out of pocket that is real money. Abbott Lingo at 9.0 has the friendliest app for a first-time user and its coaching layer explains what a glucose spike actually means, which most competitors leave you to figure out alone. The standard G7 at 8.9 remains the reference for accuracy. FreeStyle Libre 3 Plus at 8.8 has the smallest sensor in the category and it is the one I recommend to anyone bothered by the physical presence of the device. Practical guidance for readers in Taiwan: check pharmacy availability and local pricing before committing to a system, because sensor supply for some of these has been inconsistent here and a CGM you cannot restock is worse than not starting. Wear time and daily cost should drive your choice more than a small accuracy difference.

The most useful thing I can say about consumer CGMs is that the sensor hardware across the top of this list is genuinely close, and what you are actually choosing between is daily cost and what the app does with the data. Sensor accuracy differences between the leading products are small enough that they will rarely change a decision you make. Daily cost varies by a factor of three or more across this list once you account for sensor replacement intervals, and that difference compounds every fortnight for as long as you wear one. Calculate cost per day and let it drive the shortlist. The second question is whether you want raw data or coaching. Some products give you numbers and leave interpretation to you, which suits someone who already understands their own patterns. Others wrap the data in guidance and structured programmes, which costs more and helps people who want to be told what to change. The Dexcom Stelo holds first at 9.3 because it delivers Dexcom sensor quality at the lowest daily cost here with no prescription required. The Dexcom G7 15 Day at 9.1 extends wear time, which lowers cost per day further for people who need clinical-grade accuracy.

Stelo holds first because it made continuous glucose monitoring accessible without a prescription while keeping Dexcom's sensor accuracy underneath. That combination is what opens the category to people using CGM for metabolic curiosity rather than diabetes management, and that is the larger population. The G7 15 Day at second extends wear time, and wear time is the single biggest lever on daily cost. Going from ten days to fifteen cuts your annual sensor spend by a third, which changes whether someone stays on CGM past the first month. Lingo at third is built around coaching rather than raw numbers, and for a first time user the interpretation layer is more valuable than another decimal place of accuracy. The standard G7 at fourth remains the clinical reference point, and the FreeStyle Libre 3 Plus at fifth is the most widely available option globally. Nothing shifted this week. My guidance for newcomers is to treat the first two weeks as calibration of your own expectations, because everyone spikes on some foods and the useful information is your pattern rather than any single reading. Judge the trend across weeks.

The Dexcom Stelo holds first at 9.3 and accessibility is a large part of why. Stelo is available without a prescription for people not using insulin, which opens continuous glucose monitoring to anyone wanting to understand how their own body responds to food, sleep and stress. That accessibility, combined with Dexcom's sensor accuracy record, is what puts it first.

For anyone managing diabetes with insulin, the Dexcom G7 15 Day at 9.1 and G7 at 8.9 remain the clinical standard, with the fifteen day wear time meaningfully reducing both cost per day and the number of insertions per year. The FreeStyle Libre 3 Plus at 8.8 is the strongest alternative and its sensor is the smallest here.

The Eversense 365 at 8.6 does something genuinely different with an implanted sensor lasting a full year, and for someone who dislikes adhesive sensors or reacts to them, that is a meaningful option worth discussing with a clinician.

One framing point for readers using these without a diagnosis. Glucose responses to identical meals vary considerably between individuals and even day to day within the same person, so treat single readings as noise and look at patterns over weeks. And a spike after eating is normal physiology rather than a problem. If you have a diagnosed condition, your clinician's guidance supersedes anything on this page.